Evaluation of national institute for health and care excellence guidance for ruptured abdominal aortic aneurysms by emulating a hypothetical target trial.
aortic aneurysm
endovascular aneurysm repair
guidelines
infrarenal
open repair
ruptured
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
05
2023
accepted:
17
07
2023
medline:
14
8
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
epublish
Résumé
This retrospective study evaluates the performance of UK National Institute for Health and Care Excellence (NICE) Guidelines on management of ruptured abdominal aortic aneurysms in a "real world setting" by emulating a hypothetical target trial with data from two European Aortic Centers. Clinical data was retrospectively collected for all patients who had undergone ruptured endovascular aneurysm repair (rEVAR) and ruptured open surgical repair (rOSR). Survival analysis was performed comparing NICE compliance to usual care strategy. NICE compliers were defined as: female patients undergoing rEVAR; male patients >70 years old undergoing rEVAR; and male patients ≤70 years old undergoing rOSR. Hemodynamic instability was considered additionally. This multicenter study included 298 patients treated for rAAA. The majority of patients were treated with rOSR (186 rOSR vs. 112 rEVAR). Overall, 184 deaths (68 [37%] with rEVAR and 116 [63%] with rOSR) were observed during the study period. Overall survival under usual care was 69.2% at 30 days, 56.5% at one year, and 42.4% at 5 years. NICE compliance gave survival outcomes of 73.1% at 30 days, 60.2% at 1 year and 42.9% at 5 years. The risk ratios at these time points, comparing NICE-compliance to usual care, were 0.88, 0.92 and 0.99, respectively. We support NICE recommendations to manage men below the age of 71 years and hemodynamic stability with rOSR. There was a slight survival advantage for NICE compliers overall, in men >70 years and women of all ages.
Identifiants
pubmed: 37576114
doi: 10.3389/fcvm.2023.1219744
pmc: PMC10419256
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1219744Informations de copyright
© 2023 Eilenberg, Waduud, Davies, Bailey, Scott, Wolf, Sotir, Lakowitsch, Kaider, Heinze, Brostjan, Domenig and Neumayer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Ann Surg. 2013 Aug;258(2):248-56
pubmed: 23549424
Br J Surg. 2010 Apr;97(4):496-503
pubmed: 20155793
Eur J Vasc Endovasc Surg. 2004 Sep;28(3):262-9
pubmed: 15288629
Control Clin Trials. 1996 Aug;17(4):343-6
pubmed: 8889347
J Vasc Surg. 2013 Oct;58(4):1091-105
pubmed: 24075109
Ann Surg. 2012 Oct;256(4):651-8
pubmed: 22964737
Biometrics. 2011 Dec;67(4):1406-13
pubmed: 21627630
Am J Epidemiol. 2016 Apr 15;183(8):758-64
pubmed: 26994063
J Vasc Surg. 2006 Dec;44(6):1140-7
pubmed: 17145413
Int J Surg. 2017 Oct;46:198-202
pubmed: 28890409
Cochrane Database Syst Rev. 2014 Jul 21;(7):CD005261
pubmed: 25042123
Eur J Vasc Endovasc Surg. 2006 Nov;32(5):506-13; discussion 514-5
pubmed: 16887369
J Endovasc Ther. 2009 Oct;16(5):554-64
pubmed: 19842719
Vasc Endovascular Surg. 2011 Nov;45(8):717-9
pubmed: 22262115
Eur Heart J. 2011 Jul;32(14):1704-8
pubmed: 21362706
Ann Surg. 2009 Nov;250(5):818-24
pubmed: 19809296
Eur J Vasc Endovasc Surg. 2004 Sep;28(3):229-33
pubmed: 15288624
Eur J Vasc Endovasc Surg. 2018 May;55(5):625-632
pubmed: 29503083
J Vasc Surg. 2008 Nov;48(5):1092-100, 1100.e1-2
pubmed: 18971032
Br J Surg. 2014 Feb;101(3):216-24; discussion 224
pubmed: 24469620
Eur J Vasc Endovasc Surg. 2015 Jan;49(1):10-6
pubmed: 25488513
J Vasc Surg. 1991 Feb;13(2):348-50
pubmed: 1990175